News & Media
Study unravels the earliest cellular genesis of lung adenocarcinoma
February 2024
Findings could lead to earlier detection and intervention.
Tumor-infiltrating B cells and plasma cells influence early-stage lung cancer biology, immunotherapy responses
September 2022
Single-cell study provides valuable resource to identify new immunotherapy strategies.
Single-cell map of early stage lung cancer and normal lung sheds light on tumor development, new therapeutic targets
May 2021
Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung cancer and surrounding normal lung tissue at single-cell resolution, providing a valuable resource for studying tumor development and identifying new therapeutic targets.
Lung cancer in nonsmokers: The latest research
April 2021
Smoking is the No. 1 cause of lung cancer. Yet, about 20% of lung cancers deaths occur in people who have never smoked, according to the American Cancer Society. Researchers here at MD Anderson, and across the U.S., are working to understand how and why lung cancer develops in non-smokers.
Researchers analyze precursor lesions to define earliest genetic changes in lung cancer
October 2017
Despite significant advances in lung cancer treatment, new approaches for early detection and prevention remain limited because the earliest stages of lung cancer development remain unclear. In a recent study, published in Cancer Research, MD Anderson researchers have uncovered gene mutation and expression changes in lung cancer precursor cells to define the earliest events driving tumor progression.
Cells appearing normal may actually be harbingers of lung cancer
March 2014
Tissue analysis near tumors holds promise for earlier detection, new treatments.